Filing Details

Accession Number:
0000899243-18-023638
Form Type:
4
Zero Holdings:
No
Publication Time:
2018-08-31 16:05:26
Reporting Period:
2018-08-29
Accepted Time:
2018-08-31 16:05:26
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1527599 Synlogic Inc. SYBX Pharmaceutical Preparations (2834) 261824804
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1714565 Francis Paul Miller C/O Synlogic, Inc.
301 Binney Street, Suite 402
Cambridge MA 02142
Chief Scientific Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2018-08-29 1,658 $9.77 67,477 No 4 S Direct
Common Stock Disposition 2018-08-30 1,342 $9.76 66,135 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
No 4 S Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 18, 2018.
  2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.75 to $9.80, inclusive.
  3. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.75 to $9.77, inclusive.